Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.
about
Pathogenesis of human immunodeficiency virus infectionInactivation of HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS)Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophagesDrug level monitoring in a double-blind multicenter trial: false-positive zidovudine measurements in AIDS clinical trials group protocol 019.The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.Enhanced binding of antibodies to neutralization epitopes following thermal and chemical inactivation of human immunodeficiency virus type 1.Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.Lipid composition and fluidity of the human immunodeficiency virus.Effect of heat on viral protein production and budding in cultured mammalian cells.The effects of indomethacin and naproxen on zidovudine pharmacokineticsConcentrate safety and efficacy.Fluorescence polarization immunoassay for zidovudine.Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future.Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.Blocking of human immunodeficiency virus infection depends on cell density and viral stock ageSusceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolatesHuman Immunodeficiency Virus (HIV).Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests.Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.Reducing the infectivity of blood components--what we have learned.Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice.HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications.Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.Heat treating breast milk as an infant feeding option.A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens.A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1.Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study.Inactivation of human immunodeficiency virus type I in human milk: effects of intrinsic factors in human milk and of pasteurization.Detection of human immunodeficiency virus-1 nucleic acid on inactivated filter paper disks by polymerase chain reaction and microtiter plate assay.Thermostability of human immunodeficiency virus (HIV-1) in a liquid matrix is far higher than that of an ecotropic murine leukemia virus.The AIDS epidemic in haemophilia patients II: pursuing absolute viral safety of clotting factor concentrates 1985-1988.Novel therapies and current clinical progress in hemophilia A.[HTLV and "donating" milk].
P2860
Q24634681-5D1A04DF-BCA0-4372-A928-84793F6B2F3DQ24802478-8055DA40-8FCF-4D7C-B643-3C9C10A3E994Q28342606-5985A19B-4E01-45AF-99C8-3B433ED29CCFQ33744056-C9A4CCCA-F168-49A1-BC94-0156C5D913A0Q33799039-182A51B9-95E2-4A4A-B765-E6501BF53681Q33806303-6D970989-8E86-4E52-B104-216BBE9F43F0Q33895058-DBDABAF5-6CE3-4505-B6A8-B634B13578EBQ34048036-349A5999-4F65-47BF-88F5-BB1C44116FD7Q34314955-80D2412C-04F7-4BFB-A6D7-7AD21EE312DFQ34345495-04D0FF2D-F36D-4AFF-9AD5-978A67082E9FQ34636847-14379CF4-B9C3-48E6-A001-D9C29D1E8709Q35343146-6A3FA5FF-A247-4DA8-8EFA-20821A7C410AQ35817146-701ED036-E0B2-4A99-84D6-B68391B597E8Q36391604-87FB1391-AFF0-403C-8296-EF6AD0B31E53Q36643604-4B02F8EE-2ED2-4594-B25E-FDCD08942A3FQ36695580-C6D14369-53BE-4567-BF60-6295E943CCFDQ36944912-D9A094CC-1CB1-44B4-8E98-66CA92C37C42Q37045832-317132B2-1A28-41A4-BE70-C48D9F838199Q39758110-172DADA2-8BA7-462B-9737-44D53D140F53Q40205314-46C56ACB-05F5-492A-A502-E5D884213F99Q40505351-000C6F70-AF38-4982-81C9-C11F2980C5FEQ40756790-5DC0694A-0E5E-4636-991A-0AC4EE420262Q40761966-FB8015EF-7C53-434C-B229-C55C1E862244Q40942917-C904A097-3B87-4D85-8BAD-FC735444AA00Q42264778-6D2A68AA-26D1-4484-BD5F-AA48AAA9621BQ42281858-F3E3E39C-C90E-400F-8DDA-E5A4A9008D61Q43172585-009C4FC0-4918-4F12-8CAB-E0D519BF9F69Q43201449-DFB2BA1F-5F18-47D6-9EC2-5C38F2966D30Q43201730-2D60098F-85F6-4FE4-9F04-4DA626A1EAB8Q43713614-B1D8515D-1FF1-4C45-B2BF-09A5E874267BQ44098333-705F9E87-8EB7-4AD1-986F-693E7602B8AAQ44881280-5F0E3185-AEF4-47EF-A0B4-B209E4D4F245Q45419969-10A61718-A205-4344-A115-7C28A21720ACQ45419974-1C6E4FFF-8C9D-4C56-B779-87B636AF0C03Q45773248-5DB9990D-4B5E-43E1-AA3C-A239FD6ACE23Q45784915-C218A352-E18A-4925-AB58-F7FE6D182281Q45846803-8C0BE717-17DF-4651-9155-E9FA21807035Q45881380-E95EB4E9-DF0D-4F8E-B26D-C201F5176387Q49745450-E35A5A62-3673-4151-A7C7-28B6467EA65AQ55239253-FF747045-5F8F-4A31-B73A-4E087A8CF803
P2860
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@ast
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@en
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@nl
type
label
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@ast
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@en
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@nl
prefLabel
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@ast
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@en
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@nl
P2093
P2860
P356
P1476
Thermal inactivation of the ac ...... ence to antihemophilic factor.
@en
P2093
P2860
P304
P356
10.1172/JCI112045
P407
P577
1985-08-01T00:00:00Z